Lifesprout
Baltimore
About Lifesprout
LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. They offer revolutionary products for aesthetic and regenerative medicine. They have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2020)
- Website: lifesproutbio.com
- Phone: +1 410 800 0740
Industries & Categories
Biotechnology, Emergency Medicine, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lifesprout-130738 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.